Cover Image
Market Research Report

Europe Protein Sequencing Market Forecast 2020-2028

Published by Inkwood Research Product code 928600
Published Content info 90 Pages
Delivery time: 2-3 business days
Price
Back to Top
Europe Protein Sequencing Market Forecast 2020-2028
Published: March 16, 2020 Content info: 90 Pages
Description

KEY FINDINGS

The Europe protein sequencing market is anticipated to register a CAGR of 6.29% over the estimated period of 2020-2028. The high growth potential of the European market owing to the ongoing developments in the next-generation sequencing techniques. Data analysis software, R&D and technological innovation of the sequencing platforms, application of cloud computing to stire data, and data storage and management are the factors fueling the market growth in the region.

MARKET INSIGHTS

The growth of the European market of protein sequencing is studied on the basis of the markets situated in the countries in the region such as Italy, Russia, Poland, Germany, Belgium, France, the UK, and the rest of Europe that includes Denmark, Netherlands, Spain, Sweden, and others. The Russian market is showcasing growth due to the improving biotech and healthcare industries. The state initiatives have given a strong drive to establish new manufacturing facilities in the country. The new factory opened by R-Pharm will support the production of Biosimilars and biologics focused on treating cancer and autoimmune diseases. In Belgium, the market is flourishing due to the presence of high quality research institutes. In addition, biopharma organizations are manufacturing and developing assets and operating on a global scale.

In Poland, the dynamic growth of the domestic biotechnological market owing to innovative research projects carried out by academic institutions and the biotech companies, as well as by the foreign investments pouring into the biotech sector, the protein sequencing market is witnessing an emerging growth. Additionally, Poland is becoming the epicenter for biotech startups and pharmaceutical companies. The Netherlands has an extraordinary reputation in medicine. Many multinational companies are investing in Holland as the country is at the forefront of biopharmaceutical research and technology.

COMPETITIVE INSIGHTS

Agilent Technologies, Inc, SGS SA, Proteome factory, Selvita, Shimadzu Corporation, etc. are some of the leading companies operating in the region.

Our report offerings include:

Explore key findings of the overall market

Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

Market forecasts for a minimum of 9 years, along with three years of historical data for all segments, sub-segments, and regions

Market Segmentation cater to a thorough assessment of key segments with their market estimations

Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Table of Contents
Product Code: 30225

Table of contents

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. GROWING FOCUS ON TARGET-BASED DRUG DEVELOPMENT
    • 3.2.2. DEVELOPMENTS IN MASS SPECTROMETRY AND ANALYTICAL TECHNIQUES
    • 3.2.3. ADVANCES IN COMPUTATIONAL PROTEOMICS
  • 3.3. KEY RESTRAINTS
    • 3.3.1. SHORTAGE OF TRAINED RESEARCHERS AND LABORATORY PROFESSIONALS
    • 3.3.2. EXORBITANT COST LEVIED BY INFRASTRUCTURE

4. KEY ANALYTICS

  • 4.1. KEY INVESTMENT INSIGHTS
  • 4.2. PORTER'S FIVE FORCE ANALYSIS
    • 4.2.1. BUYER POWER
    • 4.2.2. SUPPLIER POWER
    • 4.2.3. SUBSTITUTION
    • 4.2.4. NEW ENTRANTS
    • 4.2.5. INDUSTRY RIVALRY
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE

5. MARKET BY PRODUCT AND SERVICE

  • 5.1. REAGENTS AND CONSUMABLES
  • 5.2. INSTRUMENTS
    • 5.2.1. EDMAN DEGRADATION
    • 5.2.2. MASS SPECTROMETRY
  • 5.3. ANALYSIS PRODUCT
  • 5.4. PROTEIN SEQUENCING SERVICES

6. MARKET BY TECHNOLOGY

  • 6.1. MASS SPECTROMETRY
  • 6.2. EDMAN DEGRADATION

7. MARKET BY APPLICATION

  • 7.1. ACADEMIA
  • 7.2. BIOPHARMACEUTICALS
  • 7.3. BIOTECHNOLOGY RESEARCH

8. GEOGRAPHICAL ANALYSIS

  • 8.1. EUROPE
    • 8.1.1. UNITED KINGDOM
    • 8.1.2. GERMANY
    • 8.1.3. FRANCE
    • 8.1.4. ITALY
    • 8.1.5. RUSSIA
    • 8.1.6. BELGIUM
    • 8.1.7. POLAND
    • 8.1.8. REST OF EUROPE

9. COMPANY PROFILES

  • 9.1. SHIMADZU CORPORATION
  • 9.2. AGILENT TECHNOLOGIES INC
  • 9.3. THERMOFISHER SCIENTIFIC INC
  • 9.4. PROTEOME FACTORY
  • 9.5. WATER CORPORATION
  • 9.6. BIOINFORMATICS SOLUTION
  • 9.7. CHARLES RIVER LABORATORIES INC
  • 9.8. SELVITA
  • 9.9. RAPID NOVOR
  • 9.10. SGS SA
  • 9.11. BRUKER CORPORATION
  • 9.12. TAKARA BIO

List of Tables

  • TABLE 1: MARKET SNAPSHOT - PROTEIN SEQUENCING
  • TABLE 2: EUROPE PROTEIN SEQUENCING MARKET, BY PRODUCT AND SERVICE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 3: EUROPE PROTEIN SEQUENCING MARKET, BY PRODUCT AND SERVICE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 4: EUROPE PROTEIN SEQUENCING MARKET, BY INSTRUMENTS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: EUROPE PROTEIN SEQUENCING MARKET, BY INSTRUMENTS, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 6: EUROPE PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 7: EUROPE PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 8: EUROPE PROTEIN SEQUENCING MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 9: EUROPE PROTEIN SEQUENCING MARKET, BY APPLICATION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 10: EUROPE PROTEIN SEQUENCING MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 11: EUROPE PROTEIN SEQUENCING MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)

List of Figures

  • FIGURE 1: KEY INVESTMENT INSIGHTS
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: EUROPE PROTEIN SEQUENCING MARKET, GROWTH POTENTIAL, BY PRODUCT AND SERVICE, IN 2019
  • FIGURE 6: EUROPE PROTEIN SEQUENCING MARKET, BY REAGENTS AND CONSUMABLES, 2020-2028 (IN $ MILLION)
  • FIGURE 7: EUROPE PROTEIN SEQUENCING MARKET, BY INSTRUMENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 8: EUROPE PROTEIN SEQUENCING MARKET, GROWTH POTENTIAL, BY INSTRUMENTS, IN 2019
  • FIGURE 9: EUROPE PROTEIN SEQUENCING MARKET, BY EDMAN DEGRADATION, 2020-2028 (IN $ MILLION)
  • FIGURE 10: EUROPE PROTEIN SEQUENCING MARKET, BY MASS SPECTROMETRY, 2020-2028 (IN $ MILLION)
  • FIGURE 11: EUROPE PROTEIN SEQUENCING MARKET, BY ANALYSIS PRODUCT, 2020-2028 (IN $ MILLION)
  • FIGURE 12: EUROPE PROTEIN SEQUENCING MARKET, BY PROTEIN SEQUENCING SERVICES, 2020-2028 (IN $ MILLION)
  • FIGURE 13: EUROPE PROTEIN SEQUENCING MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2019
  • FIGURE 14: EUROPE PROTEIN SEQUENCING MARKET, BY MASS SPECTROMETRY, 2020-2028 (IN $ MILLION)
  • FIGURE 15: EUROPE PROTEIN SEQUENCING MARKET, BY EDMAN DEGRADATION, 2020-2028 (IN $ MILLION)
  • FIGURE 16: EUROPE PROTEIN SEQUENCING MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2019
  • FIGURE 17: EUROPE PROTEIN SEQUENCING MARKET, BY ACADEMIA, 2020-2028 (IN $ MILLION)
  • FIGURE 18: EUROPE PROTEIN SEQUENCING MARKET, BY BIOPHARMACEUTICALS, 2020-2028 (IN $ MILLION)
  • FIGURE 19: EUROPE PROTEIN SEQUENCING MARKET, BIOTECHNOLOGY, 2020-2028 (IN $ MILLION)
  • FIGURE 20: EUROPE PROTEIN SEQUENCING MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 21: UNITED KINGDOM PROTEIN SEQUENCING MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 22: GERMANY PROTEIN SEQUENCING MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 23: FRANCE PROTEIN SEQUENCING MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 24: ITALY PROTEIN SEQUENCING MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 25: RUSSIA PROTEIN SEQUENCING MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 26: BELGIUM PROTEIN SEQUENCING MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 27: POLAND PROTEIN SEQUENCING MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 28: REST OF EUROPE PROTEIN SEQUENCING MARKET, 2020-2028 (IN $ MILLION)
Back to Top